Products & Services | GenomeWeb

Products & Services

Premium

Bioo Scientific has introduced the T3 Conjugation Kit for targeted in vivo delivery of siRNAs or other RNAi agents.

The T3 technology involves a carrier to an antibody that is specific to a receptor or other extracellular domain specific to the targeted cell or tissue type. The conjugate can then be loaded with an RNAi molecule.

According to the company, the kit can also be used for the in vitro delivery of siRNAs in primary cells or cell lines with mixed populations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.